Your browser doesn't support javascript.
loading
Efficacy and Safety of Delayed-release Dimethyl Fumarate for Relapsing-remitting Multiple Sclerosis in Prior Interferon Users: An Integrated Analysis of DEFINE and CONFIRM.
Fernández, Óscar; Giovannoni, Gavin; Fox, Robert J; Gold, Ralf; Phillips, J Theodore; Potts, James; Okwuokenye, Macaulay; Marantz, Jing L.
Afiliação
  • Fernández Ó; Department of Neurology, Instituto de Investigación Biomédica de Málaga, Hospital Regional Universitario, Málaga University, Málaga, Spain.
  • Giovannoni G; Blizard Institute, Queen Mary University of London, London, United Kingdom.
  • Fox RJ; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio.
  • Gold R; St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Phillips JT; Multiple Sclerosis Program, Baylor Institute for Immunology Research, Dallas, Texas, USA.
  • Potts J; Biogen, Cambridge, Massachusetts, USA.
  • Okwuokenye M; Biogen, Cambridge, Massachusetts, USA. Electronic address: macaulay.okwuokenye@biogen.com.
  • Marantz JL; Biogen, Cambridge, Massachusetts, USA.
Clin Ther ; 39(8): 1671-1679, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28751099

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Fumarato de Dimetilo / Imunossupressores Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Recidivante-Remitente / Fumarato de Dimetilo / Imunossupressores Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article